Rating History for Outlook Therapeutics Inc. (OTLK) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for OTLK
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/28/2025 Eddie Hickman Downgrade Neutral
(Buy)		 N/A
(N/A)		 2.38
(0.41)		 -82.77% Details